Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
NBI-77860
.
Show all posts
Showing posts with label
NBI-77860
.
Show all posts
Thursday, April 2, 2015
FDA grants orphan drug status to NBI-77860 for treatment of congenital adrenal hyperplasia
›
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor ant...
›
Home
View web version
